The DOI matches its Crossref record.
Prostaglandin E2 at priming of naive CD4+ T cells inhibits acquisition of ability to produce IFN-γ and IL-2, but not IL-4 and IL-5
Abstract
We investigated the effect of prostaglandin E2 on the acquisition of cytokine-producing ability by naive CD4+ T cells in human cord blood. Naive CD4+ T cells were stimulated for 3 days with mouse monoclonal anti-CD3 Ab, then washed and expanded in IL-2-containing medium for 3 more days. These activated T cells produced IL-2, IL-4, IL-5, and IFN-γ upon stimulation with PMA and ionomycin. PGE2 added at priming of naive T cells inhibited the production of IL-2 and IFN-γ, but not of IL-4 and IL-5, in a dose-dependent manner. This change in the cytokine production profile induced by PGE2 was maintained in T cells restimulated with anti-CD3 in the absence of PGE2, expanded by IL-2, and stimulated with PMA and ionomycin. The mRNA expression of IFN-γ and IL-2, but not that of IL-4, was also decreased in these cells. Forskolin and dibutyryl cAMP had a similar effect. PGE2 must exist at an early stage of T cell activation to inhibit priming for IL-2 and IFN-γ production. PGE2 also showed this effect, even in the presence of exogenous IFN-γ, at the primary stimulation. These results indicate that PGE2 inhibits the acquisition of the ability to produce IL-2 and IFN-γ by acting directly on naive T cells. Our results suggest that PGE2 plays a role in facilitating the development of the Th2-type cytokine production profile.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Type 1/Type 2 Immunity in Infectious Diseases
Spellberg, B., & Edwards, J. E. (2001) · Clinical Infectious Diseases · doi:10.1086/317537 · Cited by 911
Hata, A. N., & Breyer, R. M. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.06.003 · Cited by 840
Promoting tissue regeneration by modulating the immune system
Julier, Z., Park, A. J., Briquez, P. S., & Martino, M. M. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.01.056 · Cited by 766
Biomaterials: Foreign Bodies or Tuners for the Immune Response?
Mariani, E., Lisignoli, G., Borzì, R. M., & Pulsatelli, L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030636 · Cited by 706
Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases
Lucey, D. R., Clerici, M., & Shearer, G. M. (1996) · Clinical Microbiology Reviews · doi:10.1128/cmr.9.4.532 · Cited by 666
Okazaki, K., Uchida, K., Ohana, M., Nakase, H., Uose, S., Inai, M., Matsushima, Y., Katamura, K., Ohmori, K., & Chiba, T. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70264-2 · Cited by 538
Self-citationBoniface, K., Bak-Jensen, K. S., Li, Y., Blumenschein, W. M., McGeachy, M. J., McClanahan, T. K., McKenzie, B. S., Kastelein, R. A., Cua, D. J., & de Waal Malefyt, R. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082293 · Cited by 479
Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function
Vigano, S., Alatzoglou, D., Irving, M., Ménétrier-Caux, C., Caux, C., Romero, P., & Coukos, G. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00925 · Cited by 420
Receptors for prostaglandin E2 that regulate cellular immune responses in the mouse
Nataraj, C., Thomas, D. W., Tilley, S. L., Nguyen, M., Mannon, R. B., Koller, B. H., & Coffman, T. M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13640 · Cited by 287
SLPI and elafin: one glove, many fingers
Williams, S. E., Brown, T. I., Roghanian, A., & Sallenave, J.-M. (2006) · Clinical Science · doi:10.1042/cs20050115 · Cited by 280
Receptors for prostaglandin E2 that regulate cellular immune responses in the mouse
Nataraj, C., Thomas, D. W., Tilley, S. L., Nguyen, M., Mannon, R., Koller, B. H., & Coffman, T. M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200113640 · Cited by 278
Rieser, C., Böck, G., Klocker, H., Bartsch, G., & Thurnher, M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.9.1603 · Cited by 274
Staeva-Vieira, T. P., & Freedman, L. P. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.3.1181 · Cited by 263
Sympathetic modulation of immunity: Relevance to disease
Bellinger, D. L., Millar, B. A., Perez, S., Carter, J., Wood, C., ThyagaRajan, S., Molinaro, C., Lubahn, C., & Lorton, D. (2008) · Cellular Immunology · doi:10.1016/j.cellimm.2007.09.005 · Cited by 254
Calder, P. C. (2010) · Clinical Nutrition · doi:10.1016/j.clnu.2009.11.003 · Cited by 81
The immunological consequences of injury
Ni Choileain, N., & Redmond, H. P. (2006) · The Surgeon · doi:10.1016/s1479-666x(06)80018-1 · Cited by 73
Lysosomal phospholipase A2: A novel player in host immunity to Mycobacterium tuberculosis
Schneider, B. E., Behrends, J., Hagens, K., Harmel, N., Shayman, J. A., & Schaible, U. E. (2014) · European Journal of Immunology · doi:10.1002/eji.201344383 · Cited by 35
Metadata
- Authors
- Katamura, K., Shintaku, N., Yamauchi, Y., Fukui, T., Ohshima, Y., Mayumi, M., & Furusho, K.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1995-11
- Volume
- 155
- Issue
- 10
- Pages
- 4604-4612
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1554649625
- Cited by
- 200
- References
- 0
- FWCI
- 9.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.